Virtus ETF Advisers LLC Zentalis Pharmaceuticals, Inc. Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 22,713 shares of ZNTL stock, worth $52,694. This represents 0.03% of its overall portfolio holdings.

Number of Shares

22,713

Previous 9,683 134.57%

Holding current value

$52,694

Previous $35,000 94.29%

% of portfolio

0.03%

Previous 0.02%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.7 - $4.03 $35,181 - $52,510	13,030 Added 134.57%	22,713 $68,000
Q3 2024 Nov 14, 2024	BUY	$2.9 - $4.57 $504 - $795	174 Added 1.83%	9,683 $35,000
Q2 2024 Aug 14, 2024	BUY	$4.09 - $16.13 $15,210 - $59,987	3,719 Added 64.23%	9,509 $38,000
Q1 2024 May 15, 2024	SELL	$10.83 - $16.49 $4,321 - $6,579	-399 Reduced 6.45%	5,790 $91,000
Q4 2023 Feb 15, 2024	BUY	$9.84 - $20.13 $21,421 - $43,823	2,177 Added 54.26%	6,189 $93,000
Q3 2023 Nov 07, 2023	SELL	$19.63 - $28.29 $7,910 - $11,400	-403 Reduced 9.13%	4,012 $80,000
Q2 2023 Aug 14, 2023	SELL	$17.41 - $30.05 $11,316 - $19,532	-650 Reduced 12.83%	4,415 $124,000
Q1 2023 May 15, 2023	SELL	$16.14 - $24.94 $31,392 - $48,508	-1,945 Reduced 27.75%	5,065 $87,000
Q4 2022 Feb 14, 2023	BUY	$18.07 - $25.6 $39,591 - $56,089	2,191 Added 45.47%	7,010 $141,000
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $667 - $1,047	33 Added 0.69%	4,819 $104,000
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $46,870 - $136,738	2,617 Added 120.65%	4,786 $134,000
Q1 2022 May 16, 2022	SELL	$41.58 - $80.89 $5,654 - $11,001	-136 Reduced 5.9%	2,169 $100,000
Q4 2021 Feb 14, 2022	SELL	$66.92 - $84.79 $99,643 - $126,252	-1,489 Reduced 39.25%	2,305 $194,000
Q3 2021 Nov 15, 2021	SELL	$46.83 - $73.5 $9,272 - $14,553	-198 Reduced 4.96%	3,794 $253,000
Q2 2021 Aug 10, 2021	SELL	$37.41 - $62.25 $68,348 - $113,730	-1,827 Reduced 31.4%	3,992 $212,000
Q1 2021 May 17, 2021	BUY	$35.69 - $52.72 $3,854 - $5,693	108 Added 1.89%	5,819 $252,000
Q4 2020 Feb 12, 2021	BUY	$31.71 - $57.97 $181,095 - $331,066	5,711 New	5,711 $297,000

Others Institutions Holding ZNTL

# of Institutions

147

Shares Held

65.3M

Call Options Held

43.2K

Put Options Held

21.7K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $132M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Zentalis Pharmaceuticals, Inc. Transaction History